Want to create an interactive transcript for this episode?
Podcast: Research To Practice | Oncology Videos
Episode: Non‑Small Cell Lung Cancer | Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer
Description: Featuring perspectives from Drs Alexander Spira and Helena Yu, including the following topics: Introduction What is an antibody-drug conjugate? (0:00) "HER2-Positive" Non-Small Cell Lung Cancer (NSCLC) Case: A woman in her mid 50s with HER2 insertion in exon 20 — Dr Yu (8:42) Targeting HER3 in NSCLC Case: A man in his early 60s with lung cancer with an EGFR mutation — Dr Yu (25:23) TROP2-Directed Treatment Case: A woman in her early 50s with lung cancer with a KRAS G12V mutation — Dr Spira (36:57) Case: A woman in her mid 60s with metastatic NSCLC and an EGFR exon 19 deletion — Dr Spira (39:32) Novel Agents...